Search Results - "VERBURG, F. A"

Why and how optical molecular imaging should further be catalyzed by nuclear medicine and molecular imaging: report from the EANM piloting group by Vonk, J., Dierckx, R. A.J.O., Keereweer, S., Vahrmeijer, A.L., Verburg, F.A., Kruijff, S.

Get full text

Patients with high-risk differentiated thyroid cancer have a lower I-131 ablation success rate than low-risk ones in spite of a high ablation activity by Winter, J., Winter, M., Krohn, T., Heinzel, A., Behrendt, F.F., Tuttle, R.M., Mottaghy, F.M., Verburg, F.A.

“…Summary Objective To examine success rates in strictly defined high‐risk differentiated thyroid cancer (DTC) patients who received a high‐activity (≥5550 MBq)…”
Get full text

Reference ranges for analytes of thyroid function in children by Verburg, F A, Kirchgässner, C, Hebestreit, H, Steigerwald, U, Lentjes, E G W M, Ergezinger, K, Grelle, I, Reiners, C, Luster, M

“…Promptly detecting pediatric thyroid dysfunction requires age-appropriate reference ranges for serum thyroid-stimulating hormone (TSH), serum free thyroxine…”
Get more information

Short-term severe thyroid hormone deficiency does not influence sleep parameters by Koehler, C., Ginzkey, C., Kleinsasser, N. H., Hagen, R., Reiners, C., Verburg, F. A.

“…Purpose The influence of short-term severe thyroid hormone deficiency on sleep is currently still unknown. Several studies have demonstrated an effect of…”
Get full text

Controversies in Radioiodine Treatment of Low- and Intermediate-risk Thyroid Cancer by Eilsberger, F., Verburg, F.A.

“…In differentiated thyroid cancer, radioiodine therapy (RIT) is usually carried out after thyroidectomy. Although the potent beneficial effects of radioiodine…”
Get full text

Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison by Giovanella, L, Campenni, A, Treglia, G, Verburg, F A, Trimboli, P, Ceriani, L, Bongiovanni, M

“…To compare mutation analysis of cytology specimens and (99m)Tc-MIBI thyroid scintigraphy for differentiating benign from malignant thyroid nodules in patients…”
Get full text

The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer by Porres, D, Pfister, D, Thissen, A, Kuru, T H, Zugor, V, Buettner, R, Knuechel, R, Verburg, F A, Heidenreich, A

“…BACKGROUND: Non-prostatic bed recurrence of prostate cancer (PCa) is usually treated with androgen deprivation therapy (ADT). We analyzed the impact of salvage…”
Get full text

Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow by Giovanella, L, Suriano, S, Ceriani, L, Verburg, F A

Get more information

Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it? by VERBURG, F. A, LIPS, C. J. M, LENTJES, E. G. W. M, DE KLERK, J. M. H

“…To investigate the usefulness of thyroglobulin mRNA (Tg-mRNA) detection in peripheral blood in the follow-up of papillary and follicular (differentiated)…”
Get full text

The limit of detection in scintigraphic imaging with I-131 in patients with differentiated thyroid carcinoma by Hänscheid, H, Lassmann, M, Buck, A K, Reiners, C, Verburg, F A

“…Radioiodine scintigraphy influences staging and treatment in patients with differentiated thyroid carcinoma. The limit of detection for fractional uptake in an…”
Get more information

Hybrid FDG-PET/MRI for Diagnosis and Clinical Management of Patients with Suspected Perihilar Cholangiocarcinoma: A Feasibility Pilot Study by de Jong, D. M., Chehin, K., Meijering, T. L.N., Segbers, M., van Driel, L. M.J.W., Bruno, M. J., Groot Koerkamp, B., IJzermans, J. N.M., Verburg, F. A., de Lussanet de la Sabloniere, Q. G., Dwarkasing, R. S.

“…Purpose Recently introduced hybrid 2-[18 F]-fluoro-2-deoxy-D-glucose (18 F-FDG) Positron Emission Tomography (PET) combined with Magnetic Resonance Imaging…”
Get full text

Value of diagnostic radioiodine scintigraphy and thyroglobulin measurements after rhTSH injection by Verburg, F A, de Keizer, B, de Klerk, J M H, Lentjes, E G W M, Lips, C J M, van Isselt, J W

“…Measurements of thyroglobulin (Tg) levels 72 h after administration of recombinant human thyrotropin (rhTSH) are recommended by the manufacturer in the…”
Get more information

Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients by Verburg, F A, Wäschle, K, Reiners, C, Giovanella, L, Lentjes, E G W M

“…The aim of the study was to determine the impact of heterophile antibodies on the measurement of serum thyroglobulin (Tg), thyroglobulin recovery, and…”
Get more information

The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I by Verburg, F A, Verkooijen, R B T, Stokkel, M P M, van Isselt, J W

“…Dosimetry studies have shown that activities of 131I as small as 10-20 MBq may cause a stunning effect. A result of this stunning effect may be a lower success…”
Get more information

Evaluation of the BRAHMS KRYPTOR thyroglobulin "mini-recovery" test in thyroid healthy subjects by Verburg, F A, Grelle, I, Giovanella, L, Reiners, C

“…The aim of the work was to compare the automated thyroglobulin (Tg) assay on the automated BRAHMS KRYPTOR platform (hTG KRYPTOR) to the established BRAHMS Tg…”
Get more information

Relationship between antithyroglobulin autoantibodies and thyroglobulin recovery rates using different thyroglobulin concentrations in the recovery buffer by Verburg, F A, Hartmann, D, Grelle, I, Giovanella, L, Buck, A K, Reiners, C

“…The aim of the work was to examine the relationship between thyroglobulin autoantibody (TgAb) levels and the Tg recovery rate (TgRR) using different…”
Get more information

Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma by Feldt-Rasmussen, U, Verburg, F A, Luster, M, Cupini, C, Chiovato, L, Duntas, L, Elisei, R, Rimmele, H, Seregni, E, Smit, J W A, Theimer, C, Giovanella, L

“…Differentiated thyroid cancer is a rare malignancy, but leaves numerous survivors for life-long follow-up. The cornerstone in current guidelines for follow-up…”
Get more information

One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer by Dietlein, Markus, Verburg, F. A., Luster, M., Reiners, C., Pitoia, F., Schicha, H.

“…The guidelines for the management of patients with thyroid nodules and differentiated thyroid carcinoma (DTC) recently published by the American Thyroid…”
Get full text

The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy by Verburg, F A, Mäder, U, Grelle, I, Visser, T J, Peeters, R P, Smit, J W A, Reiners, C

“…The aim of the study was to investigate the changes in the thyroid axis setpoint after long-term suppressive levothyroxine therapy for differentiated thyroid…”
Get more information

Calcium stimulated calcitonin measurement: a procedural proposal by Verburg, F A, Reiners, C, Grelle, I, Barth, H, Fassnacht, M, Luster, M

“…Human calcitonin (hCT) is a tumor marker essential to the diagnosis and follow-up of medullary thyroid cancer (MTC). Current consensus recommends hCT…”
Get more information